Premier Health Reports 2024 Fourth Quarter Results
11 December 2024 - 8:59AM
Premier Health of America Inc. (TSXV:
PHA) (the
“
Corporation”), a leading Canadian Healthtech
company, announces it has filed its Audited Annual Consolidated
Financial Statements and MD&A for its financial year ended on
September 30th, 2024.
Highlights |
(in thousands of Canadian dollars) |
|
Sept 30, 2024(3 months) |
Sept 30, 2023(3 months) |
Sept 30, 2024(12 months) |
Sept 30, 2023(12 months) |
Revenues |
|
33,459 |
|
23,405 |
|
158,191 |
|
90,390 |
|
Gross margin (1) |
|
5,326 |
|
6,036 |
|
27,895 |
|
23,345 |
|
Gross margin as a % of revenues |
|
15.9 |
% |
25,8 |
% |
17,6 |
% |
25.8 |
% |
Adjusted EBITDA (1) |
|
994 |
|
2,073 |
|
6,559 |
|
8,227 |
|
Impairment of Goodwill |
|
- |
|
1,500 |
|
5,500 |
|
1,500 |
|
Net Loss |
|
(2,272 |
) |
(1,933 |
) |
(12,486 |
) |
(1,703 |
) |
(1) See the
Corporation’s MD&A for details on these non-GAAP measures.
Summary
- Adjusted EBITDA for the quarter was
$1.0M ($2.1M for the same period in 2023), mainly driven by a
decline in the Quebec per diem business.
- Net Loss for the quarter was $2.3M
(loss of $1.9M for the same period in 2023)
The effects of the implementation of Quebec’s
Bill 10 continued impacting the Per Diem segment during this
quarter. Hours billed remained low, but somewhat stabilized. As a
reminder, Bill 10 imposes capped rates and a series of restrictions
for using independent labor in Quebec. The Travel Nurse’s and
northern communities’ services are performing to our satisfaction.
Markets outside Quebec are stable.
As a result of the downtrend of its Per Diem
business, the Company will reorganize its operating model in Quebec
to increase efficiency and reduce costs to adapt to the new
regulations in that province. The plan includes strategies aimed at
lowering the operational overhead, capturing synergies within the
group, as well as reducing corporate spending. Overall, these
measures are expected to improve EBITDA by around $4.7M as compared
to FY2024. In addition, FY2024 acquisition costs and non-recurring
items totaling $2.7M are not expected to be incurred again in 2025,
further improving next year’s expected EBITDA. While some of these
changes have already been deployed, the bulk of the plan will take
effect in early 2025.
“Our acquisition of Solutions Staffing last
November was a key strategic decision in light of the situation in
the province of Quebec. We are adapting and rolling out a plan to
remain competitive and profitable in that province. As we move
through the current turbulences, we will concentrate our efforts on
the travel nurse segment across Canada. In 2025 our focus will be
on cost reduction, debt reduction and organic growth,” said Martin
Legault, CEO of Premier Health.
More information can be found in the Company’s
quarterly financial statements and MD&A as available on
sedarplus.ca.
About Premier Health
Premier Health is a leading Canadian Healthtech
company that provides a comprehensive range of outsourced services
solutions for healthcare needs to governments, corporations, and
individuals. Premier Health uses its proprietary
LiPHe® platform to lead the digital transformation of the
healthcare services sector, providing patients with faster, more
affordable, and more accessible care.
Non-GAAP Measures
Earnings before interest, taxes, depreciation,
and amortization (“EBITDA”), is calculated as the net profit
(loss), before non-recurring items excluding acquisition and
transaction costs, non-cash expenses (including loss from disposal
of assets, impairments, amortization, and depreciation), change in
fair values, interest expense, net of interest income and income
tax expense (recovery). Adjusted EBITDA excludes Share-based
compensation and unusual items, as determined from time to time.
Gross margin is either used as a number or a percentage. As a
number, it means Revenues minus Direct Costs. When used as a
percentage, it means the ratio of Revenues minus Direct Costs to
Revenues. More detail can be found in PHA’s Management Discussion
and Analysis.
For Further Information Please
Contact:
Mr. Jean-Robert PronovostVice President Corporate
DevelopmentPremier Health of America
Inc.jrpronovost@premierhealth.ca / 1 800 231 9916 |
Mr. Guy DaoustChief Financial OfficerPremier Health of
America Inc.gdaoust@premierhealth.ca / 1 800 231 9916 |
Neither TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
CAUTIONARY STATEMENT REGARDING
FORWARD-LOOKING INFORMATION:
This press release contains forward-looking
information within the meaning of applicable securities legislation
which reflects the current plans and expectations of the
Corporation with respect to future events and financial
performance. All statements other than statements of historical or
current facts may be forward-looking information. Forward-looking
information includes statements that are predictive in nature,
depend upon or refer to future events or conditions, or include
words such as ‘believes’, ‘continues’, ‘expects’, ‘projects’,
‘anticipates’, ‘plans’, ‘estimates’, ‘seeks’, ‘intends’, ‘targets’,
‘forecasts’, or negative or grammatical versions thereof and other
similar expressions, or future or conditional verbs such as ‘may’,
‘will’, ‘should’, ‘would’ and ‘could’. Forward-looking information
in this press release includes, but is not limited to, statements
with respect to the execution of the Corporation’s growth strategy.
Forward-looking information is based on management’s plans,
estimates, projections, beliefs and opinions as at the date of this
release, and the assumptions related to those plans, estimates,
projections, beliefs and opinions may change; therefore, they are
presented for the purpose of assisting the Corporation’s security
holders in understanding management’s views at such time regarding
those future outcomes and may not be appropriate for other
purposes. Although the forward-looking information contained in
this release is based on assumptions which the Corporation believes
are reasonable, there can be no assurance that actual results will
be consistent with such forward-looking information. The
forward-looking information in this release relate only to events
or information as of the date on which the statements are made and,
except as specifically required by applicable securities laws, the
Corporation undertakes no obligation to update or revise publicly
any forward-looking information, whether as a result of new
information, future events or otherwise, after the date on which
the statements are made or to reflect the occurrence of
unanticipated events. There can be no assurance that the
forward-looking information will prove to be accurate. These
statements should not be read as guarantees of future performance
or results. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results,
performance, or achievements to be materially different from those
implied by such statements. The Corporation assumes no
responsibility to update or revise forward-looking information to
reflect new events or circumstances unless required by law. These
factors and others are more fully discussed in the filings of the
Corporation with Canadian securities regulatory authorities
available at www.sedarplus.ca
Premier Health of America (TSXV:PHA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Premier Health of America (TSXV:PHA)
Historical Stock Chart
From Dec 2023 to Dec 2024